FR1573808A - - Google Patents

Info

Publication number
FR1573808A
FR1573808A FR1573808DA FR1573808A FR 1573808 A FR1573808 A FR 1573808A FR 1573808D A FR1573808D A FR 1573808DA FR 1573808 A FR1573808 A FR 1573808A
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
Other languages
French (fr)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Application granted granted Critical
Publication of FR1573808A publication Critical patent/FR1573808A/fr
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/10—Spiro-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/60—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D211/62—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals attached in position 4
    • C07D211/66—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals attached in position 4 having a hetero atom as the second substituent in position 4
FR1573808D 1962-06-22 1963-06-22 Expired FR1573808A (zh)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US20462362A 1962-06-22 1962-06-22

Publications (1)

Publication Number Publication Date
FR1573808A true FR1573808A (zh) 1969-07-11

Family

ID=22758700

Family Applications (6)

Application Number Title Priority Date Filing Date
FR1573808D Expired FR1573808A (zh) 1962-06-22 1963-06-22
FR948240A Active FR3043M (fr) 1962-06-22 1963-09-20 Médicament a base d'une nouvelle série de 1-aryl-4-oxo-1,3,8-triazaspiro-(4,5)-décanes, substitués en position 8 ou leurs sels pour le traitement d'affections mentales.
FR948243A Active FR2988M (fr) 1962-06-22 1963-09-20 Médicament pour le traitement d'affections mentales et pour combattre la douleur, a base d'une nouvelle série de 1-phényl-4-oxo-8-(aryl-pentényl)-1,3,8-triazaspiro (4,5) décanes.
FR948244A Active FR3059M (fr) 1962-06-22 1963-09-20 Médicament pour le traitement des troubles mentaux et cardiovasculaires contenant une nouvelle série de 1-phényl-4-oxo-1,3,8-triazaspiro-[4,5]-décanes ou leurs sels.
FR948242A Active FR2987M (fr) 1962-06-22 1963-09-20 Médicament a base d'une nouvelle série de 8-[2-(1,4-benzodioxannyl)-méthyl]-1,3,8-triazaspiro (4,5)décanes, ainsi que de leurs sels.
FR948241A Active FR2986M (fr) 1962-06-22 1963-09-20 Médicament a base de nouveaux 1-aryl-4-oxo-8-aralcoyle-1,3,8-triazaspiro(4,5)décanes, ainsi que leurs sels a action analgésique.

Family Applications After (5)

Application Number Title Priority Date Filing Date
FR948240A Active FR3043M (fr) 1962-06-22 1963-09-20 Médicament a base d'une nouvelle série de 1-aryl-4-oxo-1,3,8-triazaspiro-(4,5)-décanes, substitués en position 8 ou leurs sels pour le traitement d'affections mentales.
FR948243A Active FR2988M (fr) 1962-06-22 1963-09-20 Médicament pour le traitement d'affections mentales et pour combattre la douleur, a base d'une nouvelle série de 1-phényl-4-oxo-8-(aryl-pentényl)-1,3,8-triazaspiro (4,5) décanes.
FR948244A Active FR3059M (fr) 1962-06-22 1963-09-20 Médicament pour le traitement des troubles mentaux et cardiovasculaires contenant une nouvelle série de 1-phényl-4-oxo-1,3,8-triazaspiro-[4,5]-décanes ou leurs sels.
FR948242A Active FR2987M (fr) 1962-06-22 1963-09-20 Médicament a base d'une nouvelle série de 8-[2-(1,4-benzodioxannyl)-méthyl]-1,3,8-triazaspiro (4,5)décanes, ainsi que de leurs sels.
FR948241A Active FR2986M (fr) 1962-06-22 1963-09-20 Médicament a base de nouveaux 1-aryl-4-oxo-8-aralcoyle-1,3,8-triazaspiro(4,5)décanes, ainsi que leurs sels a action analgésique.

Country Status (9)

Country Link
BE (1) BE633914A (zh)
CH (1) CH462835A (zh)
DE (1) DE1470125C3 (zh)
DK (1) DK119880B (zh)
FI (1) FI46967C (zh)
FR (6) FR1573808A (zh)
GB (1) GB1043141A (zh)
NO (1) NO117368B (zh)
SE (1) SE311019B (zh)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2162168A1 (zh) * 1971-12-03 1973-07-13 Sumitomo Chemical Co

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4080328A (en) * 1971-07-13 1978-03-21 Sumitomo Chemical Company, Limited N-substituted heterocyclic derivatives and preparation thereof
US4066772A (en) * 1975-07-21 1978-01-03 Janssen Pharmaceutica N.V. 1,3-Dihydro-1-[3-(1-piperidinyl)propyl]-2H-benzimidazol-2-ones and related compounds
NZ181256A (en) * 1975-07-21 1978-04-28 Janssen Pharmaceutica Nv 1-(w-benzazol-11-ylalkyl)-piperidine derivatives and pharmaceutical compositions containing certain of these derivatives
DK139684A (da) * 1983-04-11 1984-10-12 Janssen Pharmaceutica Nv N-aryl-alpha-amino-carboxamider
US5244902A (en) * 1989-08-21 1993-09-14 Beth Israel Hospital Association Topical application of spiperone or derivatives thereof for treatment of pathological conditions associated with immune responses
US5703088A (en) * 1989-08-21 1997-12-30 Beth Israel Deaconess Medical Center, Inc. Topical application of spiperone or derivatives thereof for treatment of pathological conditions associated with immune responses
US5574041A (en) * 1990-03-16 1996-11-12 Beth Israel Hospital Association Use of spiperone derivatives as immunosuppressant agents
US5693645A (en) * 1992-12-23 1997-12-02 Beth Israel Deaconess Medical Center, Inc. Use of spiperone or spiperone derivatives as immunosuppressant agents
DE19610397A1 (de) * 1996-03-16 1997-09-18 Krewel Meuselbach Gmbh Gewinnung von Fluspirilen-Suspensionen
US6277991B1 (en) 1998-05-18 2001-08-21 Novo Nordisk A/S 1,3,8-triazaspiro[4.5]decanones with high affinity for opioid receptor subtypes
EP1080091A1 (en) * 1998-05-18 2001-03-07 Novo Nordisk A/S Novel 1,3,8-triazaspiro[4.5]decanones with high affinity for opioid receptor subtypes
US6262066B1 (en) 1998-07-27 2001-07-17 Schering Corporation High affinity ligands for nociceptin receptor ORL-1
ATE289307T1 (de) * 1998-10-23 2005-03-15 Pfizer 1,3,8-triazaspiro(4,5) decanon verbindungen als orl1-receptor agonisten
US7459461B2 (en) 2001-10-19 2008-12-02 Ortho-Mcneil Pharmaceutical, Inc. Phosphonic acid compounds as inhibitors of serine proteases
DE102005038141A1 (de) * 2005-08-12 2007-02-15 Grünenthal GmbH Substituierte 8-(3-Aminopropyl)-1-phenyl-1,3,8-triaza-spiro[4.5]decan-4-on-Derivate
CN103052636B (zh) * 2010-06-18 2016-03-09 阿尔托斯治疗有限责任公司 D2拮抗剂及其合成方法和使用方法
IT201800007580A1 (it) * 2018-07-27 2020-01-27 Maria Cecilia Hospital Spa Composti 1,3,8-triazaspiro e loro uso come medicamenti

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2162168A1 (zh) * 1971-12-03 1973-07-13 Sumitomo Chemical Co

Also Published As

Publication number Publication date
CH462835A (de) 1968-09-30
DE1470125C3 (de) 1980-07-10
SE311019B (zh) 1969-05-27
DE1470125A1 (de) 1969-05-08
FR3059M (fr) 1965-01-11
BE633914A (zh)
DE1470125B2 (zh) 1979-10-31
FI46967B (zh) 1973-05-02
FR3043M (fr) 1965-01-04
FR2986M (fr) 1964-12-07
FI46967C (fi) 1973-08-10
FR2987M (fr) 1964-12-07
GB1043141A (en) 1966-09-21
FR2988M (fr) 1964-12-07
DK119880B (da) 1971-03-08
NO117368B (zh) 1969-08-04

Similar Documents

Publication Publication Date Title
FI46967B (zh)
BE616548R (zh)
BE614757A (zh)
BE614566A (zh)
BE634789A (zh)
BE633063A (zh)
BE632060A (zh)
BE630721A (zh)
BE629367A (zh)
BE628584A (zh)
BE628111A (zh)
BE627871A (zh)
BE627812A (zh)
BE627294A (zh)
BE627173A (zh)
BE626825A (zh)
BE635421A (zh)
BE616785A (zh)
BE616490A (zh)
BE616386A (zh)
BE616166A (zh)
BE615962A (zh)
BE615849A (zh)
BE615804A (zh)
BE615523A (zh)